Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Nippon India Pharma Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.85
2.09
NAV
₹556.11
₹42.91
Fund Started
10 May 2004
25 Jun 2018
Fund Size
₹9044.23 Cr
₹6624.58 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
5.29%
5.40%
3 Year
18.85%
23.49%
5 Year
12.13%
15.24%
Equity
97.64%
96.05%
Cash
2.35%
3.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.78% |
Lupin Ltd. | 7.45% |
Dr. Reddy's Laboratories Ltd. | 6.68% |
Cipla Ltd. | 6.15% |
Divi's Laboratories Ltd. | 5.46% |
Apollo Hospitals Enterprise Ltd. | 5.27% |
Mankind Pharma Ltd. | 4.03% |
Sai Life Sciences Ltd. | 3.49% |
Ajanta Pharma Ltd. | 3.46% |
Max Healthcare Institute Ltd. | 3.32% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 May 2004
25 Jun 2018
